Structural alterations in 3q27 affecting the BCL6 locus are among the most frequent changes in B-NHL. The aim of the present study was to establish an interphase-FISH assay for the detection of all diverse BCL6 translocations in B-NHL. Two different approaches were tested, one using a PAC-clone spanning the major breakpoint region (MBR) of BCL6 (span-assay), and another using two BAC clones flanking the MBR (flankassay). Interphase FISH with the span-assay detected the various BCL6 translocations in seven B-NHL cell lines. The dualcolor flank-assay was evaluated in two laboratories independently: in normal controls, the cutoff level for false-positive signals was 2.6%, whereas the cutoff level for false-negatives in the seven cell lines was 7.5%. To test the feasibility of the FISH strategies, 30 samples from patients with B-NHL with cytogenetic abnormalities of 3q27 were evaluated with both assays. In 21 cases, the span-assay indicated a BCL6 rearrangement. In 18 of the 21 cases, the dual-color flank-assay confirmed the translocation including 12 different partner chromosomal loci. The three false-positive cases detected with the span-assay showed trisomy of chromosome 3 by cytogenetic analyses, and they were correctly classified as non-rearranged with the flank-assay. In summary, our FISH strategy using two differently labeled flanking BCL6 BAC probes provides a robust, sensitive, and reproducible method for the detection of common and uncommon abnormalities of BCL6 gene in interphase nuclei. The routine application of this assay to patients with B-NHL will allow the assessment of the diagnostic and prognostic significance of BCL6 rearrangements. Leukemia (2001) 15, 1475-1484.
Introduction
Reciprocal chromosomal translocations involving band 3q27 are frequent in B cell non-Hodgkin's lymphomas (B-NHL). 1, 2 The involved gene in most cases is a zinc finger gene, BCL6, and has been found juxtaposed not only to the immunoglobulin (IG) genes, but also to a variety of other genes, some of which have been characterized by molecular cloning. [3] [4] [5] [6] [7] [8] These genes include not only constitutively expressed genes such as histone H4, but also genes with possible oncogenic Breakpoints at 3q27 are predominantly located in the 5Ј untranslated region of BCL6, including the promoter and the first non-coding intron; this region has been termed the major breakpoint region (MBR). In such translocations, the BCL6 coding exons are juxtaposed downstream to the promoter derived from the reciprocal chromosomal partner, resulting in deregulated BCL6 expression. 9, 10 However, there has been no clear link between the presence of BCL6 chromosomal translocations and deregulated BCL6 expression and it is possible that clonal, somatic mutations and deletions within the same regulatory region of the BCL6 gene may also contribute to deregulated expression. 8, 10 Chromosomal translocations involving 3q27 or rearrangements of the BCL6 gene have been identified in about 40% of diffuse large B-NHL (DLBCL), but they have also been found at lower frequency in other subtypes of B-NHL. 2, 7, 11, 12 Whether translocations affecting 3q27 or BCL6 rearrangements are of prognostic value in DLBCL remains controversial. One study reported a favorable prognosis for patients with BCL6 rearrangements detected by Southern blot. 11 However, these data have not been confirmed. 7, 13 Resolution of this point demands an assay that will allow the routine detection of all BCL6 translocations. This has been hampered by a number of different factors. Conventional cytogenetic analysis is limited by the location of BCL6 in the terminal portion of chromosome 3q and by the presence of complex three-way translocations within the BCL6 locus.
14 Additionally, cytogenetically detectable breakpoints in 3q27 might not affect the BCL6 gene. For a regular polymerase chain reaction (PCR) assay, a complex set of primers for each corresponding rearrangement would need to be designed to detect all possible rearrangements. 8 Currently, the only available techniques for the screening of most BCL6 translocations are Southern blot analyses and long-distance inverse PCR, but these methods are limited by the necessity for high molecular weight DNA, which is not always available from every patient and by the technical difficulties associated with these methods. 7, 8, [11] [12] [13] Furthermore, the frequent presence of deletions and mutations within the BCL6 MBR may confound results of Southern blot analysis. Additionally, the expression of BCL6 protein does not correlate with BCL6 gene rearrangement and therefore immunohistochemical studies cannot be used as a surrogate marker for BCL6 translocations. 15 
Leukemia
Fluorescence in situ hybridization (FISH) is a sensitive method for the routine identification of leukemia and lymphoma-associated chromosomal translocations. Using large DNA probes such as yeast artificial chromosome (YAC), P1 artificial chromosome (PAC) or bacterial artificial chromosome (BAC) spanning common breakpoints, it is possible to detect most translocations within a specific gene, despite a large number of partner chromosomes. 16 However, the systematic evaluation of any single color assay is technically difficult on patient samples. Thus, for diagnostic purposes, a more specific approach using two differentially labeled probes from both partner chromosomes leading to the detection of the specific fusion signals on interphase nuclei, such as in the t(8;14)(q24;q32), t(14;18)(q32;q21) or t(11;14)(q13;q32) translocations, is commonly used. [17] [18] [19] [20] In the case of promiscuous genes, such as MLL or ETV6, these assays are not of value, but translocations can be detected using FISH probes flanking the MLL or ETV6 breakpoints. 21 Few previous studies have attempted the detection of BCL6 rearrangements using FISH. Two of these reports established assays which were only applicable to metaphase cells, 22, 23 whereas another study performed on interphase cells was limited to the identification of BCL6 translocations involving IGH. 24 To date, there has not been a FISH method available for the routine detection of all BCL6 translocations.
We report a novel strategy using two differentially labeled flanking BCL6 BAC probes, which provides a robust, sensitive, and reproducible method for the detection of all common and uncommon abnormalities of BCL6 in B-NHL by interphase FISH.
Materials and methods

Cell lines and patients with B-NHL
Seven B-NHL cell lines with different BCL6 translocations previously characterized at the cytogenetic and/or molecular levels were selected for this study: VAL, 25 MD903, 26 OciLy8, 14 ,27 MD901, 6 Karpas 231, 28, 29 YM 30 and the B-NHL cell line CTB-1. 31 The CTB-1 cell line has been reported on the basis of cytogenetic analysis alone to have a t(14;22)(q32;q11); however, we have found by FISH, molecular methods, and cross-species color banding (RxFISH) an exchange of chromosomal material from 3q to 14q, resulting in a complex four way translocation at the IGH locus, which will be described in greater detail elsewhere (Sonoki et al, manuscript in preparation). All cell lines were grown in RPMI-1640 medium supplemented with 10% fetal calf serum.
Samples from 30 patients with B-NHL (21 DLBCL, seven follicular lymphoma, one MALT lymphoma, one B-NHL of indeterminate histological subtype) with cytogenetic abnormalities of 3q27 were also evaluated. Twenty-five samples were from lymph node, two were from bone marrow, two were from peripheral blood, and one was from a pleural effusion. Cytogenetic studies on samples from the patients and cell lines were performed and described according to standard methods using either G-or R-banding techniques. 32 Additionally, cross-species color karyotyping (RxFISH) was performed in OCI-Ly8 and CTB-1 cell lines as reported. 33 Results of cytogenetic and FISH analyses are summarized in Table 1 . 
Probes used for FISH
FISH methods
FISH studies were performed on fixed cells from cytogenetic samples. In three patients without available material, FISH was performed on G-banded slides stored at room temperature between 1 and 8 years. DNA from the probes was directly labeled with Spectrum Red (SR) and Spectrum Green (SG) (Vysis, Downers Grove, IL, USA) by nick translation. FISH procedure was performed as reported previously. 21 For each experiment, at least 200 interphase nuclei, as well as 20 metaphase cells were examined by two independent observers. The samples were examined in Valencia with a Nikon Eclipse 400 fluorescence microscope (Nikon Corp, Tokyo, Japan) and in Kiel with a Zeiss Axioskop 2 fluorescence microscope (Zeiss, Oberkochen, Germany) equipped with appropriate filter sets and documented using the QuipsXL Genetic Workstation (Vysis) and the ISIS3 software (MetaSystems, Altlussheim, Germany), respectively.
Molecular studies
Screening of genomic libraries for BCL6 intron 1-containing clones:
PCR for detection of intron 1 of BCL6 corresponding to the MBR region was performed using the following primers: 5Ј CTCTTGCCAAATGCTTTG 3Ј and 5Ј AAGCAGTTTGCAAGCGAG 3Ј, generating a 465 bp fragment in the wild-type gene. After an initial denaturation cycle at 94°C for 8 min, 30 cycles of denaturation (94°C for 30 s), annealing (60°C for 30 s) and extension (72°C for 30 s), and a final extension cycle at 72°C for 5 min, the samples were loaded on to a 1% agarose gel with ethidium bromide.
Southern blot and IGH LDI-PCR to detect BCL6 rearrangements:
In cases where sufficient high molecular weight DNA was available, Southern blot for BCL6 gene rearrangements was performed as described. 34 DNA was digested with add(5)(p12),del(6)(q13q25),der(9)t(4;9)(q21;p22)del(4)(q31q33),der(10)t(5;10)(p12;q11), der(14)t(2;14)(q31;q32),der(18)t(14;18)(q32;q21),+22,der (22) der(9)del(9)(p22)t(1;9)(q13;q34),−13,−14 [30] 22 DLBCL PB 49,XX,+X,t(1;3)(p34;q27),der(6)t(6;7)(q13;q22),der (7) 32 LDI-PCR from the IGHJ segments and from 5Ј S to amplify the derivative partner chromosome was performed as described. 35, 36 LDI-PCR products were cloned into pTOPO (Invitrogen, San Diego, CA, USA) and sequenced.
Results
Design of FISH assays and selection of DNA probes
Two different FISH approaches were evaluated. The first assay used PAC and BAC clones spanning the non-coding intron 1 of BCL6 including the MBR (span-assay). For this purpose, several DNA clones containing BCL6 gene sequences from different genomic libraries were mapped and tested by PCR for the presence of intron 1. Three clones mapping to 3q27 in normal donors and containing BCL6 intron 1 were selected: two PACs, RMC03P056 and RMC03P061, and RPCI-11 BAC 211G3. The latter clone contains the entire BCL6 gene according to sequence analyses using the BLAST algorithm and is part of the contig HPFCctg 13301 (http://genome.wustl.edu/). The second assay used two BAC clones flanking the MBR (flank-assay), also selected from the contig HPFCctg 13301 (RPCI-11 528E8 and 690C8). According to sequence comparisons and physical mapping data, neither probes contained BCL6 sequences and therefore were negative for the presence of intron 1. BAC 528E8 was centromeric, and 690C8 telomeric to the MBR, and the distance between them was estimated at about 200 kb. A schematic representation of the probes in the BCL6 region is shown in Figure 1 . All probes were shown to map to 3q27 and to be non-chimeric by FISH on metaphase cells from four donors with a normal karyotype.
Evaluation of the FISH assays in cell lines
To validate the span-assay, the three BCL6 probes containing the BCL6 MBR were tested on metaphase and interphase cells from the seven B-NHL cell lines with various BCL6 translocations. PAC 03P056 was split and translocated to the corresponding derivative chromosome in all of the cell lines, thus giving a three signal pattern on interphase nuclei, two corresponding to the split probe and one to the normal allele (Figure 2a) . On the contrary, PAC 03P061 was not translocated and therefore remained in the derivative chromosome 3 on metaphase spreads; a pattern corresponding to two signals was observed on interphase nuclei. Additional studies
Figure 1
Schematic map of 3q27 region including MBR breakpoint. PAC and BAC clones used for FISH assays are indicated. PAC 03P056 and PAC 03P061 both labeled in red were used in the spanassay. BAC 690C8 labeled in red and BAC 528E8 labeled in green were used in the flank-assay.
Leukemia using BAC 211G3 were performed in VAL, CTB-1 and OciLy8 cell lines, showing a partial translocation of the probe to the corresponding derivative chromosome. To confirm the t(3;14)(q27;q32) and t(3;22)(q27;q11) in Oci-Ly8, CTB-1, MD901, and MD903 cell lines with such rearrangements, IGH and IGL gene probes were co-hybridized with PAC 03P056 and PAC 03P061, respectively. In all cases, the fusion signals were identified on metaphase spreads and interphase cells, thus confirming the corresponding translocation.
To validate the flank-assay assay, the two differently labeled BACs 528E8 (red) and 690C8 (green) hybridizing centromeric and telomeric to the BCL6 gene, respectively, were also tested in four normal donors and in the seven cell lines. The normal signal pattern corresponding to two fused (overlapping) or colocalized (defined as estimated signal distance less than once the signal diameter) red-green signals were observed in the normal metaphase and interphase cells. The expected rearranged pattern for a simple balanced BCL6 translocation was defined as one fused or colocalized red-green signal corresponding to the normal chromosome 3, and two separated red and green signals (one signal diameter minimum distance) from the two derivative chromosomes (Figure 2b ). In case of complex karyotypes, gains or losses of normal or derivative chromosomes could result in variant rearranged patterns, in which the presence of one or more isolated red or green signals indicates a break in the BCL6 locus. All the experiments on positive and negative controls were evaluated in two laboratories independently on the same slides. In normal controls, 0 to 2% (mean 0.44%; s.d. 0.73%) of interphase nuclei matched the rearranged pattern and thus, were classified as false-positives (cutoff level, mean +3 s.d., 2.6%). In 98 to 100% of interphase nuclei, a normal pattern (consisting of 90% of fused or touching signals, and 10% of signals with a distance of less than one signal diameter) was found. In all the seven cell lines, irrespective of the BCL6 partner chromosome, 94 to 100% (mean 97.5%; s.d. 1.69%) of nuclei matched the rearrangement pattern (cutoff level for false-negatives, 7.5%). Interobserver variability, defined as the difference in the percentage of positive and negative rearranged cells in normal controls and cell lines detected by the two observers, was lower than 1%. Therefore, our results demonstrate our FISH assay to be a sensitive and reproducible method for the detection of different translocations of BCL6.
Evaluation of the FISH assays in samples from patients with B-NHL
To test the clinical feasibility of the two FISH strategies, samples from 30 patients with B cell NHL with cytogenetic abnormalities of 3q27 were evaluated with both assays. In 21 cases, the span-assay detected the translocation in 10-89% of interphase nuclei. In 18 cases, the dual-color flank-assay confirmed the BCL6 rearrangements in 12-95% of interphase nuclei (Figure 3) . Nevertheless, the three false-positive cases identified with the span-assay showed a total or partial trisomy 3 by cytogenetic analysis, and they were correctly classified as non-rearranged with the flank-assay (Figure 4) .
Considering the patients and cell lines together, 12 different partner chromosomal loci translocated to BCL6 were detected by the two assays involving 2p11, 3q13, 4p11, 6q15, 11q23, 12q13, 13q14, 14q32, 16p11, 16p13, 16q22 and 22q11. In five of these cases where sufficient high molecular weight DNA was available, the involvement of the BCL6 MBR was confirmed by Southern blot analysis (data not shown). Apart Leukemia a b
Figure 2
Fluorescence in situ hybridization assays for the detection of BCL6 translocations on metaphase chromosomes and interphase nuclei. (a) Span-assay. On the left side, normal localization of the BCL6 PAC 03P056 in band 3q27, with the corresponding normal pattern consisting in two signals on nuclei cells. On the right side, a translocation involving BCL6 with a chromosome termed A is represented: the PAC is split by the translocation, giving a three signal pattern on interphase nuclei, two corresponding to the split probe and one to the normal allele. (b) Flank-assay. Normal colocalization of the two differentially labeled BACs RPCI-11 528E8 (red) and 690C8 (green), hybridizing centromeric and telomeric to the BCL6 gene, respectively. The normal hybridization pattern corresponding to two fused (overlapping) or colocalized (touching) signals was observed in the normal metaphase and interphase cells (left). The expected rearranged pattern in a simple balanced BCL6 translocation was defined as one fused or colocalized red-green signal corresponding to the normal chromosome 3, and two separated red and green signals (one signal diameter minimum distance) from the two derivative chromosomes.
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Figure 3
Detection of BCL6 rearrangements in samples from patients with B-NHL by FISH. (a) Example of span-assay using PAC 03P056 labeled in red. Metaphase from a patient with DLBCL (case 16) with inv(3)(q13.2q27 or q12q29) according to cytogenetic analysis. The PAC is split by the inversion leading to two hybridization signals on the same chromosome 3 (arrowheads), confirming the inv(3)(q13.2q27) with BCL6 rearrangement. (b) Example of flank-assay using the BACs RPCI-11 528E8 (red) and 690C8 (green) in metaphase cell and interphase nuclei from a patient with FL (case 9) with a t(3;22)(q27;q11). The red-green double signal corresponds to the normal chromosome 3, whereas the single hybridization red signal corresponds to BAC 528E8 on the derivative chromosome 3, and the single hybridization green signal corresponds to BAC 690C8 translocated to the derivative chromosome 22. from the previously reported translocations most of which have now been cloned, 8, 25, 26, 30 we identified two novel partner chromosome loci at 3q13 and 12q13. In the inv(3)(q13q27) (case 16), PAC 03P056 was split whereas PAC 03P061 was completely translocated to 3q13, indicating that the breakpoint was situated at the common region within MBR (Figure 3 ). In the t(3;12)(q27;q13) (case 18), a more centromeric breakpoint to MBR within BCL6 was identified, as both PAC 03P061 and PAC 03P056 were shown to be split.
Seven patients with t(3;14)(q27;q32) and three with t(3;22)(q27;q12) were also studied using IGH and IGL gene probes combined with BCL6 PACs, respectively. In all cases, a fusion signal was also identified on interphase nuclei. These cases included a MALT lymphoma (case 10) with 12% of 
Rearrangements of chromosome 3q27 not involving BCL6
Twelve of the 30 cases (patients 19-30 in Table 1 ) with cytogenetic abnormalities of 3q27 did not show BCL6 rearrangement by FISH, including two translocations involving the IG gene loci, and other rare rearrangements. None of these cases showed BCL6 gene rearrangement using either FISH assays. In two cases with a t(3;9)(q27;p21) or a t(3;12)(q27;q12), the flanking BACs 528E8 and 690C8 were completely translocated to the derivative chromosome, indicating a centromeric breakpoint outside BCL6 at 3q27. In the other cases, the FISH analysis did not confirm the BCL6 involvement as the FISH probes remained on the derivative chromosome 3.
Complex BCL6 rearrangements detected by FISH
Complex rearrangements within the BCL6 locus were also detectable using the flank assay. In the Oci-Ly8 cell line, a complex three-way translocation t(3;14;8)(q27;q32;q24) involving the BCL6, IGH and C-MYC genes, was confirmed by standard cytogenetic analysis and RxFISH, confirming preLeukemia vious results.
14 In the CTB-1 cell line, 31 which shows by standard cytogenetics a t(14;22)(q32;q11), a BCL6-IGH gene fusion was identified by LDI-PCR. Cloning of an illegitimate switch rearrangement using primers situated in the 5Ј region of S showed a translocation involving the first intron of BCL6. The sequence of this breakpoint is shown in Figure 5a . RxFISH detected a t(8;14)(q24;q32), but no involvement of chromosome 3 was found (Figure 5b ). However, a t(3;14;8)(q27;q32;q24) similar to that present in the Oci-Ly8 cell line, involving BCL6, IGH and C-MYC, was detected by FISH (Figure 5c ).
Discussion
All currently available techniques for the identification of BCL6 translocations, such as conventional cytogenetic analysis, Southern blot analysis, or LDI-PCR, have significant technical or methodological limitations. Moreover, previously reported FISH strategies for the screening of BCL6 translocations also had important restrictions, and could only be applied to metaphase cells, 22, 23 or to cases with t(3;14)(q27;q32) on interphase nuclei. 24 We report here a novel FISH strategy using two differently labeled flanking BCL6 BAC probes which provides a robust, sensitive, and reproducible method for the detection of all common and uncommon translocations involving the BCL6 gene in interphase nuclei.
We investigated the sensitivity of our two-color interphase FISH in normal controls and cell lines. The cutoff level for false-positive signals was as low as 2.6%. In most other dualcolor flanking assays similar to ours, the reported cutoff levels have been considerably higher, ranging from 5 to 11%. [37] [38] [39] The incidence of false negatives will depend upon the normal variance of probe separation within interphase nuclei, which will be increased with widely spaced probes. The high sensitivity of our FISH assay may be explained by the short distance between the two probes, estimated at about 200 kb. In 90% of control nuclei the differentially labeled signals of the flankassay were fused or touching. Moreover, in the majority of the remaining control nuclei, the signals were separated by less than one signal diameter. Defining these colocalisations as a normal pattern significantly increased the sensitivity of the assay, and 200 cells per sample could be rapidly and easily evaluated. In other reported dual-color FISH assays, a translocation, eg a t(8;14)(q24;q32), t(14;18)(q32;q21), t(11;14) (q13;q32), or t(11;18)(q21;q21), is indicated by two fusion signals (touching or superimposed yellow signal). [17] [18] [19] [20] 37 Theoretically, the highest sensitivity of a double-color FISH assay can be achieved by using probes spanning the breakpoint regions of both translocation partners leading to two fusion signals in case of a translocation. Nevertheless, for routine use this approach is not applicable to the BCL6 gene due to its promiscuity and different translocation partners.
We also validated our dual-color assay on seven cell lines with diverse BCL6 translocations, demonstrating the cutoff level of false-negatives to be 7.5%. Most FISH reports lack such validation of the probes on a substantial number of cell lines. [17] [18] [19] [20] [21] [22] [23] [24] [37] [38] [39] The low percentage of false-negative cells indicates the high specificity of our assay, demonstrated by the extensive control studies performed. Our FISH experiments were also evaluated in two different laboratories on the same slides. Interobserver variability was very low, indicating that the evaluation is simple and reproducible.
Both FISH assays were compared on 30 patients with varied Cloning of an illegitimate switch rearrangement was performed by LDI-PCR using primers situated in the 5Ј region of S and showed a translocation involving the first intron of BCL6. Sequence derived from the CTB-1 cell line in black and underlined is compared with the germline IGH S sequence in red and the BCL6 intron 1 sequence in blue. (b) Example of RxFISH study on metaphase cell from the CTB-1 cell line. A t(8;14)(q24;q32) is shown, but no involvement of chromosome 3 was identified. This cell line was reported to have a t(14;22)(q32;q11) by standard cytogenetic analysis. 31 By using RxFISH, the t(14;22) was correctly classified as a reciprocal translocation between chromosomes 12p11 and 22q11, with the involvement of chromosome 14q32 in the complex t(3;14;8) (q27;q32;q24) shown below. (c) A complex t(3;14;8)(q27;q32;q24), involving BCL6, IGH and C-MYC genes, was detected by FISH. In the image, two probes flanking of the IGH locus (cosmid c␣1-IgH centromeric to IGH in green and PAC 1098L17 telomeric to IGH in red) were used. A red-green hybridization signal corresponds to the normal chromosome 14; both probes are translocated and therefore not detected on the derivative chromosome 14 (marked with an arrow): PAC 1098L17 (red) maps to 3q27 fusing to BCL6 (data not shown) whereas cosmid c␣1-IgH (green) maps to 8q24, fusing to c-MYC (data not shown). 3q27 translocations. The flank-assay was a superior technique, which showed a lower false-negative rate and was much easier to analyze on interphase nuclei than the spanassay. Therefore, the flanking strategy can be easily applied to patient samples without the necessity of metaphase cells. Moreover, we successfully analyzed with the flanking strategy three G-banded slides, showing BCL6 rearrangements. Therefore our assay could be applied routinely to most patients and this is one of its major advantages. Because partial or total trisomy of chromosome 3 is commonly seen in up to 10% of B cell NHL, 1,2 we were also concerned that our assays be capable of differentiating cases with trisomy 3 from those carrying true BCL6 translocations. In 18 cases, a translocation involving BCL6 was confirmed by both assays, but three other rearrangements were only detected with the spanning probes. Based on the single-color assay, the presence of three signals on interphase nuclei may reflect either trisomy or a gene translocation. Our flank-assay confirmed these three false-positive results to be caused by trisomy 3.
Our flanking strategy has been demonstrated to be of value in detecting 12 different BCL6 translocations, including common and uncommon chromosomal partners. According to extensive molecular studies, more than 95% of BCL6 translocations cluster within the MBR. [8] [9] [10] Therefore, our dual-color assay will detect all these rearrangements. It is remarkable that in this series, approximately one-third of cases with 3q27 translocations defined cytogenetically did not show BCL6 involvement. This is in agreement with previous reports. 22, 23 The results obtained in two of our cases, where the two flanking probes were translocated to the partner chromosomes, as well as in a case with a t(1;3)(q21;q27) reported by Wlodraska et al, 22 suggest that breakpoints centromeric to the BCL6 gene may be involved in some of these patients. In the other cases without BCL6 involvement according to our FISH assays, we could not rule out the possibility that some of these cases involve the alternative breakpoint region (ABR) located 200-270 kb telomeric to MBR, as reported by Chen et al 40 in a t(2;3)(q21;q27). Unfortunately, we did not have access to any cases containing such t(2;3) translocations and therefore were not able to validate our assays for the detection of breaks in the ABR.
The true prognostic significance of BCL6 rearrangements in DLBCL is an issue that remains controversial and could be addressed with the application of our dual-color assay. An initial report by Offit et al 11 in 1994 indicated that BCL6 gene rearrangement in DLBCL correlated predominantly with extranodal disease and better clinical outcome. Subsequent studies using similar Southern blot analysis, however, have not confirmed these results. 7, 13 These differences may be related to either difficulties in the identification of all heterologous BCL6 gene rearrangements with current molecular techniques (although all studies should have detected most BCL6 rearrangements) or selection bias in the inclusion of patients with enough tumor DNA for Southern blot. Additionally, our results show that cytogenetically detectable breakpoints in 3q27 might not involve BCL6. The routine application of our assay to patients with B-NHL could help to refine the true incidence of BCL6 translocations and, thus, to clarify the prognostic role of BCL6 rearrangements in these neoplasms.
However, there may be significant biological heterogeneity among the BCL6 translocations themselves. Thus, in some BCL6 translocations, it is clear that the involved gene may be deregulated, as well as BCL6 as a consequence of translocation. For example, in the cell line Karpas 231, which exhibits a t(3;11)(q27;q23.1), both BCL6 and BOB-1/OBF-1, a B cell-specific transcriptional activator, are expressed at high level. 29 The possible contribution of partner genes such as this to the pathogenesis or evolution of B cell malignancies is not known. During the preparation of this manuscript, a report based on combined use of Southern blot and LDI-PCR approaches appeared, indicating that the involvement of BCL6 with non-IG loci translocation was associated with a significantly worse outcome than those with BCL6/IG translocations. 41 Combined use of the BCL6 flanking probe set described here with the IG probes would allow this point to be assessed in a larger number of patients.
